Browse > Article

Are Medical Personnel Safe from Radiation Exposure from Patient Receiving Radioiodine Ablation Therapy?  

Kim, Chang-Guhn (Department of Nuclear Medicine, Wonkwang University School of Medicine)
Kim, Dae-Weung (Department of Nuclear Medicine, Wonkwang University School of Medicine)
Publication Information
Nuclear Medicine and Molecular Imaging / v.43, no.4, 2009 , pp. 259-279 More about this Journal
Abstract
Radioiodine ablation therapy has been considered to be a standard treatment for patient with differentiated thyroid cancer after total thyroidectomy. Patients may need to be hospitalized to reduce radiation exposure of other people and relatives from radioactive patients receiving radioiodine therapy. Medical staffs, nursing staffs and technologists sometimes hesitate to contact patients in radioiodine therapy ward. The purpose of this paper is to introduce radiation dosimetry, estimate radiation dose from patients and emphasize the safety of radiation exposure from patients treated with high dose radioiodine in therapy ward. The major component of radiation dose from patient is external exposure. However external radiation dose from these patients treated with typical therapeutic dose of 4 to 8 GBq have a very low risk of cancer induction compared with other various risks occurring in daily life. The typical annual radiation dose without shielding received by patient is estimated to be 5 to 10 mSv, which is comparable with 100 to 200 times effective dose received by chest PA examination. Therefore, when we should keep in mind the general principle of radiation protection, the risks of radiation exposure from patients are low and the medical personnel are considered to be safe from radiation exposure.
Keywords
Radioiodine ablation therapy; thyroid neoplasm; radiation protection; radiation dosimetry; internal dosimetry;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Hilditch TE, Connell JM, Davies OL, Watson WS, Alexander WD. Radiological protection guidance for radioactive patients-new data for therapeutic 131I. Nucl Med Commun 1991;12:485-95   DOI   ScienceOn
2 O'Doherty MJ, Kettle AG, Eustance CN, Mountford PJ, Coakley AJ. Radiation does rates from adult patients receiving 131I therapy for thyrotoxicosis. Nucl Med Commun 1993;14:160-8   DOI   ScienceOn
3 Jacobson AP, Plato PA, Toeroek, D. Contamination of the home environment by patients treated with iodine-131: initial results. Am J Public Health 1978;68:225-30   DOI   ScienceOn
4 Stabin MG, Stubbs JB, Toohey RE: Radiation Dose Estimates for Radiopharmaceuticals (ORNL Report NUREG/CR-6345). Oak Ridge, TN, Oak Ridge Institute for Science and Education; 1996. Also available electronically at http://orise.orau.gov/reacts/dose-estcompendia.htm. Accessed June 12, 2009
5 Hall EJ. Radiobiology for the Radiologist. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 208-9
6 International Commission on Radiological Protection. 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Ann ICRP 1991;21:82-7   PUBMED
7 National Radiological Protection Board. A national Survey of Doses to- Patients Undergoing a Selection of Routine X-ray Examinations in English Hospitals. NRPB-R200; 1986 and Survey of CT practice in the UK, Part 2: Dosimetric Aspects. NRPBR249;1991. Chilton, Didcot, Oxon
8 Royal College of Radiologists. Making the Best Use ell Department of Clinical Radiology. 4th ed. Royal College of Radiologists. London. 1998
9 Driver I, Packer S. Radioactive waste discharge quantities for patients undergoing radioactive iodine therapy for thyroid carcinoma. Nucl Med Commun 2001;22:1129-32   DOI   ScienceOn
10 Cohel BL. Catalog of risks extended and updated. Health Phys 1991;61:317-35   DOI   ScienceOn
11 Groenewald WA, Wasserman HJ. Constants for calculating ambient and directional dose equivalents from radionuclide point sources. Health Physics 1990;58:655-8   PUBMED   ScienceOn
12 Cember H. Introduction to Health Physics. 3rd ed. McGraw-Hill; 1996. p. 148
13 Cherry SR, Sorenson JA, Phelps ME. Physics in Nuclear Medicine. 3rd ed. Philadelphia: Saunders; 2003. p. 434
14 Stabin MG: MIRDOSE: Personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 1996;37:538-46   PUBMED
15 Chandra R. Nuclear Medicine Physics the basics, 5th ed. Baltimore: Williams & Wilkins; 1998. p. 64-7
16 International Commission on Radiological Protection. Release of Patients after Therapy with Unsealed Radionuclides. ICRP Publication 94. Ann ICRP 2004;34:13-27
17 Lubin, E. Definitive improvement in the approach to the treated patient as a radioactive source. J Nucl Med 2002;43:364-5   PUBMED   ScienceOn
18 Siegel JA, Marcus CS, Sparks RB. Calculating the absorbed does from radioactive patients : the line-sourceversus point-source model. J Nucl Med 2002;43:1241-4   PUBMED   ScienceOn
19 Barrington SF, Kettle AG, O'Doherty MJ, Wells CP, Somer EJ, Coakley, AJ. Radiation does rates from patients receiving iodine-131 therapy for carcinoma of the thyroid. Eur J Nucl Med 1996;23:123-30   DOI   ScienceOn
20 Wasserman H, Groenewald W, Air kerma rate constants for radionuclides. Eur J Nucl Med 1988;14:569-71   DOI   PUBMED   ScienceOn
21 Edward WW. Radiation protection in nuclear medicine In: Taveras JM, Ferrucci JT. Radiology Diagnosis Imaging Intervention. Philadelphia: J. B. Lippincott Company; 1986. p. 11
22 International Commission on Radiological Protection. Dose Coefficients for Intakes of Radionuclides by Workers. ICRP Publication 68. Ann ICRP 1994;24:13-73   PUBMED
23 Culver CM, Dworkin HJ. Radiation safety considerations for post-iodine-131 hyperthyroid therapy. J Nucl Med 1991;32:169-73   PUBMED
24 Little JB. Biologic Effects of Low-Level Radiation Exposure. In: Taveras JM, Ferrucci JT. Radiology Diagnosis Imaging Intervention. Philadelphia: J. B. Lippincott Company; 1986. p. 11
25 Hubbell JH. Photon mass attenuation and energy-absorption coefficients from 1 keV to 20 MeV. Int J Appl Radiat Isotopes 1982;33:1289-93   DOI   ScienceOn